A detailed history of Janney Montgomery Scott LLC transactions in Cerus Corp stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 64,600 shares of CERS stock, worth $116,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,600
Previous 61,600 4.87%
Holding current value
$116,280
Previous $116,000 1.72%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$1.62 - $2.04 $4,860 - $6,120
3,000 Added 4.87%
64,600 $114,000
Q1 2024

May 01, 2024

BUY
$1.66 - $2.42 $2,988 - $4,356
1,800 Added 3.01%
61,600 $116,000
Q4 2023

Feb 07, 2024

SELL
$1.25 - $2.35 $3,500 - $6,580
-2,800 Reduced 4.47%
59,800 $129,000
Q3 2023

Nov 08, 2023

SELL
$1.5 - $3.07 $24,300 - $49,734
-16,200 Reduced 20.56%
62,600 $101,000
Q2 2023

Jul 26, 2023

BUY
$1.79 - $2.9 $537 - $870
300 Added 0.38%
78,800 $194,000
Q1 2023

Apr 28, 2023

SELL
$2.65 - $3.81 $5,300 - $7,620
-2,000 Reduced 2.48%
78,500 $233,000
Q4 2022

Feb 01, 2023

SELL
$3.38 - $4.22 $507 - $633
-150 Reduced 0.19%
80,500 $294,000
Q2 2022

Aug 03, 2022

SELL
$4.41 - $5.69 $2,205 - $2,845
-500 Reduced 0.62%
80,650 $429,000
Q1 2022

May 04, 2022

BUY
$4.81 - $6.99 $28,859 - $41,940
6,000 Added 7.98%
81,150 $446,000
Q4 2021

Jan 27, 2022

SELL
$5.97 - $7.93 $31,342 - $41,632
-5,250 Reduced 6.53%
75,150 $512,000
Q3 2021

Oct 29, 2021

BUY
$4.79 - $6.68 $5,987 - $8,350
1,250 Added 1.58%
80,400 $490,000
Q2 2021

Jul 26, 2021

SELL
$5.35 - $6.35 $5,350 - $6,350
-1,000 Reduced 1.25%
79,150 $468,000
Q1 2021

Apr 27, 2021

BUY
$5.68 - $7.87 $7,384 - $10,231
1,300 Added 1.65%
80,150 $482,000
Q4 2020

Jan 25, 2021

BUY
$5.25 - $8.56 $3,412 - $5,564
650 Added 0.83%
78,850 $546,000
Q2 2020

Jul 23, 2020

BUY
$4.5 - $7.02 $24,750 - $38,610
5,500 Added 7.57%
78,200 $516,000
Q1 2020

Apr 30, 2020

BUY
$2.87 - $5.49 $14,350 - $27,450
5,000 Added 7.39%
72,700 $338,000
Q4 2019

Jan 21, 2020

BUY
$3.84 - $4.86 $51,840 - $65,610
13,500 Added 24.91%
67,700 $286,000
Q3 2019

Oct 29, 2019

BUY
$4.86 - $6.05 $20,655 - $25,712
4,250 Added 8.51%
54,200 $279,000
Q2 2019

Jul 29, 2019

SELL
$4.51 - $6.6 $7,892 - $11,550
-1,750 Reduced 3.38%
49,950 $281,000
Q1 2019

Apr 30, 2019

BUY
$5.16 - $6.85 $2,580 - $3,425
500 Added 0.98%
51,700 $322,000
Q4 2018

Feb 01, 2019

BUY
$4.89 - $7.16 $20,049 - $29,356
4,100 Added 8.7%
51,200 $260,000
Q3 2018

Nov 05, 2018

BUY
$6.89 - $7.78 $3,445 - $3,890
500 Added 1.07%
47,100 $340,000
Q2 2018

Jul 24, 2018

SELL
$5.19 - $7.25 $10,380 - $14,500
-2,000 Reduced 4.12%
46,600 $311,000
Q3 2017

Nov 15, 2017

BUY
$2.22 - $2.73 $107,892 - $132,678
48,600
48,600 $133,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.